Form 4: Clifford Sosin of CAS Investment Partners Increases Stake in Cardlytics, Inc.

Clifford Sosin, through CAS Investment Partners, has increased his firm's holdings in Cardlytics, Inc. (CDLX) with recent purchases of common stock.

Summary

• Clifford Sosin, a director and 10% owner of Cardlytics, Inc., has reported changes in beneficial ownership.
• On March 15, 2024, Sosin acquired 311,715 shares of Cardlytics common stock at a price of $13.7118 per share.
• On March 18, 2024, Sosin acquired an additional 350,000 shares of Cardlytics common stock at a price of $13.3991 per share.
• Following these transactions, Sosin's beneficial ownership in Cardlytics totals 6,023,676 shares.
• These shares are indirectly owned through Sosin Master, L.P. and CSWR Partners, L.P., for which CAS Investment Partners, LLC acts as the investment manager.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The increased stake suggests confidence, but it's just a transaction report.

Positives

• Increased investment by a significant shareholder may signal confidence in the company's future prospects.

Industry Context

This filing reflects insider activity, which is closely monitored by investors for signals about a company's prospects. Increased ownership by a significant shareholder like Sosin could be interpreted positively.

Stakeholder Impact

• Shareholders may view the increased stake positively.
• The impact on other stakeholders is likely minimal.

Key Dates